Rankings
▼
Calendar
RDNT
RadNet, Inc.
$5B
Q4 2023 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$420M
+9.5% YoY
Gross Profit
$64M
15.2% margin
Operating Income
$24M
5.8% margin
Net Income
-$2M
-0.4% margin
EPS (Diluted)
$-0.03
QoQ Revenue Growth
+4.6%
Cash Flow
Operating Cash Flow
$89M
Free Cash Flow
$49M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$2.7B
Total Liabilities
$1.9B
Stockholders' Equity
$631M
Cash & Equivalents
$343M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$420M
$384M
+9.5%
Gross Profit
$64M
$54M
+17.5%
Operating Income
$24M
$22M
+12.6%
Net Income
-$2M
-$935,000
-98.9%
Revenue Segments
Commercial Insurance1
$232M
57%
Medicare1
$96M
23%
Capitation Arrangements
$35M
9%
Medicaid1
$12M
3%
Workers' Compensation/Personal Injury1
$12M
3%
Health Care, Patient Service Other
$11M
3%
Health Care, Management Service
$6M
1%
Health Care, Other
$3M
1%
← FY 2023
All Quarters
Q1 2024 →
RDNT Q4 2023 Earnings — RadNet, Inc. Revenue & Financial Results | Market Cap Arena